Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

被引：0
作者：
Joshua D. Palmer
Deepak Bhamidipati
Andrew Song
Harriet B. Eldredge-Hindy
Joshua Siglin
Tu D. Dan
Colin E. Champ
Isabella Zhang
Voichita Bar-Ad
Lyndon Kim
Jon Glass
James J. Evans
David W. Andrews
Maria Werner-Wasik
Wenyin Shi
机构：
[1] The James Cancer Hospital and Solove Research Institute,Department of Radiation Oncology
[2] Ohio State University Wexner Medical Center,Department of Radiation Oncology
[3] Sidney Kimmel Medical College,Department of Radiation Oncology
[4] Thomas Jefferson University,Department of Radiation Oncology
[5] Sidney Kimmel Cancer Center,Department of Radiation Oncology
[6] Thomas Jefferson University,Department of Radiation Oncology
[7] James Graham Brown Cancer Center,Department of Radiation Medicine
[8] University of Louiville,Department of Neurological Surgery
[9] Hillman Cancer Center at UPMC Altoona,undefined
[10] Harold C Simmons Comprehensive Cancer Center,undefined
[11] University of Texas Southwestern,undefined
[12] UPMC Cancer Center at UPMC St. Margaret,undefined
[13] University of Pittsburgh,undefined
[14] North Shore-Long Island Jewish Medical Center,undefined
[15] Sidney Kimmel Cancer Center,undefined
[16] Thomas Jefferson University,undefined
来源：
Journal of Neuro-Oncology | 2018年 / 140卷
关键词：
Recurrent glioblastoma; Bevacizumab; Re-irradiation; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：623 / 628
页数：5
相关论文
共 50 条
  • [1] Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer, Joshua D.
    Bhamidipati, Deepak
    Song, Andrew
    Eldredge-Hindy, Harriet B.
    Siglin, Joshua
    Dan, Tu D.
    Champ, Colin E.
    Zhang, Isabella
    Bar-Ad, Voichita
    Kim, Lyndon
    Glass, Jon
    Evans, James J.
    Andrews, David W.
    Werner-Wasik, Maria
    Shi, Wenyin
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (03) : 623 - 628
  • [2] Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas
    Heo, J.
    Kim, S. H.
    Oh, Y. T.
    Chun, M.
    Noh, O. K.
    NEOPLASMA, 2017, 64 (05) : 803 - 808
  • [3] Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
    Thomas Hundsberger
    Detlef Brügge
    Paul M. Putora
    Patrik Weder
    Johannes Weber
    Ludwig Plasswilm
    Journal of Neuro-Oncology, 2013, 112 : 133 - 139
  • [4] Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
    Hundsberger, Thomas
    Bruegge, Detlef
    Putora, Paul M.
    Weder, Patrik
    Weber, Johannes
    Plasswilm, Ludwig
    JOURNAL OF NEURO-ONCOLOGY, 2013, 112 (01) : 133 - 139
  • [5] Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment
    Yonezawa, Hajime
    Ohno, Makoto
    Igaki, Hiroshi
    Miyakita, Yasuji
    Takahashi, Masamichi
    Tamura, Yukie
    Shima, Satoshi
    Matsushita, Yuko
    Ichimura, Koichi
    Narita, Yoshitaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (07) : 1028 - 1035
  • [6] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Arvold, Nils D.
    Shi, Diana D.
    Aizer, Ayal A.
    Norden, Andrew D.
    Reardon, David A.
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Dunn, Ian F.
    Golby, Alexandra J.
    Johnson, Mark D.
    Claus, Elizabeth B.
    Chiocca, E. Antonio
    Ligon, Keith L.
    Wen, Patrick Y.
    Alexander, Brian M.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 581 - 591
  • [7] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Nils D. Arvold
    Diana D. Shi
    Ayal A. Aizer
    Andrew D. Norden
    David A. Reardon
    Eudocia Q. Lee
    Lakshmi Nayak
    Ian F. Dunn
    Alexandra J. Golby
    Mark D. Johnson
    Elizabeth B. Claus
    E. Antonio Chiocca
    Keith L. Ligon
    Patrick Y. Wen
    Brian M. Alexander
    Journal of Neuro-Oncology, 2017, 135 : 581 - 591
  • [8] A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
    Dixit, Karan S.
    Sachdev, Sean
    Amidei, Christina
    Kumthekar, Priya
    Kruser, Tim J.
    Gondi, Vinai
    Grimm, Sean
    Lukas, Rimas, V
    Nicholas, Martin Kelly
    Chmura, Steven J.
    Fought, Angela J.
    Mehta, Minesh
    Raizer, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 297 - 306
  • [9] Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment
    Wenyin Shi
    Erik S. Blomain
    Joshua Siglin
    Joshua D. Palmer
    Tu Dan
    Yang Wang
    Maria Werner-Wasik
    Jon Glass
    Lyndon Kim
    Voichita Bar Ad
    Deepak Bhamidipati
    James J. Evans
    Kevin Judy
    Christopher J. Farrell
    David W. Andrews
    Journal of Neuro-Oncology, 2018, 137 : 171 - 177
  • [10] A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
    Karan S Dixit
    Sean Sachdev
    Christina Amidei
    Priya Kumthekar
    Tim J Kruser
    Vinai Gondi
    Sean Grimm
    Rimas V Lukas
    Martin Kelly Nicholas
    Steven J Chmura
    Angela J Fought
    Minesh Mehta
    Jeffrey J Raizer
    Journal of Neuro-Oncology, 2021, 155 : 297 - 306
12345